Anti-SERPINA12抗體,內(nèi)臟脂肪組織源性*蛋白酶抑制蛋白抗體產(chǎn)品經(jīng)無數(shù)次市場(chǎng)驗(yàn)證，若出現(xiàn)質(zhì)量問題可無條件換貨或退貨,詳細(xì)信息：

產(chǎn)品詢價(jià) 或（成）客服

英文名稱 SERPINA12
抗體名稱 Anti-SERPINA12抗體,內(nèi)臟脂肪組織源性*蛋白酶抑制蛋白抗體
別    名 OL 64; OL-64; OL64; Serine (or cysteine) proteinase inhibitor clade A (alpha 1 antiproteinase antitrypsin) member 12 ; Serpin A12; Serpin A12 precursor; Serpin peptidase inhibitor clade A (alpha 1 antiproteinase antitrypsin) member 12; Serpina12; SPA12_HUMAN antibody Vaspin; Visceral adipose specific serpin; Visceral adipose tissue derived serine protease inhibitor; Visceral adipose tissue-derived serine protease inhibitor; Visceral adipose-specific serpin.   
研究領(lǐng)域 心血管  細(xì)胞生物  免疫學(xué)  神經(jīng)生物學(xué)  信號(hào)轉(zhuǎn)導(dǎo)  糖尿病  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, 
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復(fù)） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 45kDa
細(xì)胞定位 分泌型蛋白 
性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human SERPINA12/Vaspin
亞    型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

上海研盟生物其它優(yōu)勢(shì)產(chǎn)品：

13050R Anti-EDAR抗體,腫瘤壞死因子受體超家族成員EDAR抗體
13052R Anti-UBR5抗體,E3泛素蛋白連接酶EDD抗體
13053R Anti-EED抗體,胚胎外胚層發(fā)育蛋白EED抗體
13054R Anti-eEF1A2抗體,翻譯延伸因子EF-1 α2抗體
13055R Anti-EEF1D抗體,延伸因子EF-1δ抗體
13058R Anti-Phospho-EEF2k(Ser359),磷酸化真核延伸因子激酶2抗體
13059R Anti-EFEMP2抗體,纖連蛋白4抗體
13060R Anti-EFS抗體,對(duì)接蛋白EFS抗體
13061R Anti-EFTUD2抗體,延伸因子結(jié)合蛋白EFTUD2抗體
13062R Anti-EGFL6抗體,表皮生長(zhǎng)因子樣蛋白6抗體
13065R Anti-EHM2抗體,EHM2蛋白抗體
13066R Anti-eIF1抗體,真核翻譯起始因子1抗體
13067R Anti-ELK4抗體,血清反應(yīng)因子輔助蛋白1抗體
13068R Anti-ELMO2抗體,吞噬細(xì)胞運(yùn)動(dòng)蛋白2抗體
13069R Anti-EMSY抗體,EMSY蛋白抗體
13070R Anti-ENOSF1抗體,烯醇化酶超家族成員1抗體
13075R Anti-ENPP5抗體,磷酸酶/磷酸二酯酶家族成員5抗體
13077R Anti-ENT1抗體,核苷轉(zhuǎn)運(yùn)蛋白ENT1抗體
13078R Anti-ENT2抗體,核苷轉(zhuǎn)運(yùn)蛋白ENT2抗體
13079R Anti-Epac2抗體,*核苷酸交換因子4抗體
13080R Anti-EPB41抗體,紅細(xì)胞膜條帶4.1蛋白抗體
13082R Anti-phospho-EphB1(Tyr928),磷酸化*蛋白激酶受體B1抗體
13084R Anti-phospho-Ephexin-1(Tyr179),磷酸化神經(jīng)細(xì)胞鳥苷酸置換因子抗體

抗體原理 
（1）特異性結(jié)合抗原：抗體本身不能直接溶解或殺傷帶有特異抗原的靶細(xì)胞，通常需要補(bǔ)體或吞噬細(xì)胞等共同發(fā)揮效應(yīng)以清除病原微生物或?qū)е虏±頁p傷。然而，抗體可通過與病毒或毒素的特異性結(jié)合，直接發(fā)揮中和病毒的作用。 
（2）激活補(bǔ)體：IgM、IgG1、IgG2和IgG3可通過經(jīng)典途徑激活補(bǔ)體，凝聚的IgA、IgG4和IgE可通過替代途徑激活補(bǔ)體。 
（3）結(jié)合細(xì)胞：不同類別的免疫球蛋白，可結(jié)合不同種的細(xì)胞，參與免疫應(yīng)答。 
（4）可通過胎盤及粘膜：免疫球蛋白G（IgG）能通過胎盤進(jìn)入胎兒血流中，使胎兒形成自然被動(dòng)免疫。免疫球蛋白A（IgA）可通過消化道及呼吸道粘膜，是粘膜局部抗感染免疫的主要因素。 
（5）具有抗原性：抗體分子是一種蛋白質(zhì)，也具有刺激機(jī)體產(chǎn)生免疫應(yīng)答的性能。不同的免疫球蛋白分子，各具有不同的抗原性。 
（6）抗體對(duì)理化因子的抵抗力與一般球蛋白相同：不耐熱，60～70℃即被破壞。各種酶及能使蛋白質(zhì)凝固變性的物質(zhì)，均能破壞抗體的作用?？贵w可被中性鹽類沉淀。在生產(chǎn)上?？捎昧蛩徜@或硫酸鈉從免疫血清中沉淀出含有抗體的球蛋白，再經(jīng)透析法將其純化。
產(chǎn)品介紹 May modulates insulin action conceivably only in the presence of its yet undefined target proteases in white adipose tissues.
Serpins are the largest and most diverse family of protease inhibitors. Most serpins control proteolytic cascades, certain serpins do not inhibit enzymes, but instead perform diverse functions such as storage (ovalbumin, in egg white), hormone carriage proteins (thyroxine-binding globulin, cortisol-binding globulin) and tumor suppressor genes (maspin). Most inhibitory serpins target chymotrypsin-like serine proteases. These enzymes are defined by the presence of a nucleophilic serine residue in their catalytic site. Some serpins inhibit other classes of protease. A number of such serpins have been shown to target cysteine proteases. These enzymes differ from serine proteases in that they are defined by the presence of a nucleophilic cysteine residue, rather than a serine residue, in their catalytic site.
SerpinA12, also known as OL-64, Visceral adipose tissue-derived serine protease inhibitor, Vaspin, Visceral adipose-specific serpin and SERPINA12, is a secreted protein which belongs to the serpin family. SerpinA12 / Vaspin is expressed in visceral adipose tissues. It may modulates insulin action conceivably only in the presence of its yet undefined target proteases in white adipose tissues. SerpinA12 / Vaspin may be the compensatory molecule in the pathogenesis of metabolic syndrome and SerpinA12 / Vaspin recombinant protein or vaspin-mimicking agents such as vaspin analogs, antibodies or small molecule agents may be the link to drug discovery and development.

運(yùn)輸方面：現(xiàn)貨供應(yīng)，一般為快遞運(yùn)輸，江浙滬隔天到，外地及偏遠(yuǎn)地方三至五天時(shí)間到貨。